Chronologic analysis of clonal evolution in acquired aplastic anemia and sMDS
Chronologic analysis of clonal evolution in acquired aplastic anemia and sMDS
复制标题
获得性再生障碍性贫血和 sMDS 克隆进化的时间分析
DOI:
10.11406/rinketsu.57.430
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
Yoshizato T
中科院分区:
文献类型:
--
作者:
平野敬和・田澤晴子・藤村一郎;Akio Taniguchi;藤村一郎;Akio Taniguchi;藤村一郎;Ichiro Fujimura (藤村一郎);Akio Taniguchi;Akio Taniguchi;平野敬和・藤村一郎・田澤晴子;藤村一郎;Akio Taniguchi;藤村一郎;藤村一郎;藤村一郎;藤村一郎;Yoshizato T
Acquired aplastic anemia (AA) is a prototype of idiopathic bone marrow failure, which is caused by immune-mediated destruction of hematopoietic progenitors but is also characterized by frequent evolution to clonal myeloid disorders, such as myelodysplastic syndromes or acute myeloid leukemia. However, the chronological behavior of the clonality and its link to myelodysplastic syndrome or acute myeloid leukemia has not been fully explored. To define the clonality and its chronological behavior in AA, we performed targeted sequencing (N= 439) in cases with AA. Somatic mutations were detected in 1/3 of our cases. Mutations were most frequently found in DNMT3A, followed by BCOR, PIGA and ASXL1. The prevalence of mutations increased with age. The clone sizes in DNMT3A and ASXL1 were prone to increase, whereas those of BCOR and PIGA were more likely to decrease or remain stable. Mutations in PIGA, BCOR and BCORL1 correlated with a better response to immunosuppressive therapy and more favorable survival. On the other hand, other mutations were associated with worse outcomes. The chronological dynamics of clonality showed marked variability and were not necessarily associated with prognosis.